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Abstract 
Background 
High salinity and temperature combined with presence of heavy metals and low oxygen 
renders deep-sea anoxic brines of the Red Sea as one of the most extreme environments on 
Earth. The ability to adapt and survive in these extreme environments makes inhabiting 
bacteria interesting candidates for the search of novel bioactive molecules. 
Methods 
Total 20 i.e. lipophilic (chloroform) and hydrophilic (70% ethanol) extracts of marine 
bacteria isolated from brine-seawater interface of the Red Sea were tested for cytotoxic and 
apoptotic activity against three human cancer cell lines, i.e. HeLa (cervical carcinoma), MCF-
7 (Breast Adenocarcinoma) and DU145 (Prostate carcinoma). 
Results 
Among these, twelve extracts were found to be very active after 24 hours of treatment, which 
were further evaluated for their cytotoxic and apoptotic effects at 48 hr. The extracts from the 
isolates P1-37B and P3-37A (Halomonas) and P1-17B (Sulfitobacter) have been found to be 
the most potent against tested cancer cell lines. 
Conclusion 
Overall, bacterial isolates from the Red Sea displayed promising results and can be explored 
further to find novel drug-like molecules. The cell line specific activity of the extracts may be 
attributed to the presence of different polarity compounds or the cancer type i.e. biological 
differences in cell lines and different mechanisms of action of programmed cell death 
prevalent in different cancer cell lines. 
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Background 
The marine environment is a rich source of unique bioactive molecules with unlimited 
chemical and functional diversity. Approximately 30,000 natural products have been isolated 
from marine organisms (http://dmnp.chemnetbase.com/intro/index.jsp) and many of the drug 
candidates are currently in clinical trials [1,2]. In the recent reports, both, deep sea water 
bodies and seafloors have been shown to be some of the most biodiverse and species-rich 
habitats on the planet [3,4]. The continuous search for new chemically diverse molecules and 
the development of new methods for culturing deep-sea microorganisms have placed the deep 
sea environment as a new frontier in the drug discovery process. The general opinion is that 
the survival of deep sea organisms in the extreme conditions of pressure, absence of light, 
low levels of oxygen, high temperature and salt concentration may have affect their primary 
and secondary metabolite profiles [5,6] which, in turn, can be suitable candidates for 
discovery of structurally unique molecules. 
Siderophore Bisucaberin [7] was the first cytotoxic compound isolated from deep-sea marine 
bacteria Alteromonas haloplanktis, collected at 3000 m depth off the coast of Aomori 
Prefecture, Japan. Lately, Homann et al. reported the isolation of peptidic siderophores 
Loihichelins A-F [8] from the cultures of heterotrophic bacterium Halomonas LOB-5 
collected from the southern rift zone of Loihi Seamount east of Hawaii. Novel cytotoxic 
phenazine derivatives [9] with unique ring system have been described from pacific sediment 
Bacillus sp. (5059 m depth). Several other compounds with significant cytotoxic activity 
which were isolated from deep-sea Bacillus and Streptomyces sp. and actinomycete have 
been described by Danielle Skropeta in a recent review [10]. In our effort to exploit the 
biodiversity of these environments, several strains of marine bacteria were isolated from 
Kebrit Deep, Nereus Deep, Discovery Deep and Erba Deep of the Red Sea [11] and evaluated 
for their cytotoxic and apoptotic potential. 
The Red Sea harbors approximately 25 deep-sea anoxic brine pools, which were formed by a 
process of re-dissolution of evaporitic deposits [12-14]. The deep-sea anoxic brines of the 
Red Sea are considered to be one of the most extreme environments on Earth, which are 
characterized by drastic changes in physicochemical conditions when compared to overlying 
seawater. This includes the increases in salinity (from 4% up to 26% salinity), temperature 
(up to 70°C), concentrations of heavy metals, and decrease in oxygen [15,16]. 
The present study describes the assessment of anticancer activity of marine microorganisms 
from the brine-seawater interface of the Red Sea. The cytotoxic activities of lipophilic, i.e. 
chloroform and hydrophilic, i.e. 70% ethanol extracts of marine bacteria isolated from deep 
sea brine pools of Red Sea, against HeLa (cervical carcinoma), MCF-7 (breast 
adenocarcinoma) and DU145 (prostate carcinoma) cell lines, were measured at 24 hr time 
point. Some of the highly active extracts were further assessed for cytotoxicity and apoptotic 
activity at 48 hr. 
Methods 
Field sampling 
Water samples from the brine-seawater interface were collected using a rosette sampler 
equipped with 10 l Niskin bottles and a conductivity-temperature-depths (CTD) unit for 
monitoring salinity, temperature, transmission, and pressure. At each sampling site, 180 l of 
samples were collected and pre-filtered through a 5.0 µm SMWP membrane (diameter 290 
mm; Millipore, Ireland) to remove suspended particles, then filter-concentrated with 
Tangential Flow Filtration (TFF) system through Durapore 0.1 µm PVDF filter (Pellicon 2 
Cassette Filter, Screen type C, size 0.5 m2, Millipore Corporation, MA, USA). After 
filtration, one liter of each concentrated sample was stored in the dark at 4°C and was used as 
inoculum. 
Source of bacterial isolates 
Twelve strains of bacteria investigated in this study were isolated from brine-seawater 
interface of deep sea brines in the Red Sea. Brine-seawater samples for bacterial isolation 
were collected from four different deep brines named Discovery Deep (2050 m), Kebrit Deep 
(1549 m), Nereus Deep (2300 m), and Erba Deep (2300 m). Each of the deep sea brine has its 
unique physicochemical composition [11]. In the Discovery deep, brine–seawater boundaries 
are characterized by strong temperature and salinity gradients [14]. 
All of the bacterial strains isolated in this study were obtained by the streak plate method 
described elsewhere [17]. All of the strains grew in 10% NaCl with the exception of one 
strain isolated from Discovery Deep. This strain was successfully isolated using 20% NaCl. 
PCR amplification 
PCR amplifications of the extracted DNA of the cultures were performed in a 25 µl reaction 
having 12.5 µl Promega PCR Master Mix (Promega, USA), 0.5 µl (final concentration 0.5 
µM) of primer 27bF (5’-AGAGTTTGATCMTGGCTCAG-3’) and 1492uR (5’-
TACCTTGTTACGACTT-3’). PCR reaction were carried out in Mastercycler (Eppendorf, 
Germany) under the following conditions: a pre-denaturation temperature of 95°C for 5 min; 
30 cycles of 95°C for 60s, 55°C for 60s, 72°C for 30s; followed by final extension at 72°C 
for 5 min. The yield and quality of the PCR products were examined on 1% (wt/vol) agarose 
gel (SeaKem GTG, Lonza, USA) stained with SYBR Safe (Invitrogen, USA), then purified 
with Illustra Exostar 1-step (GE, Healthcare, UK) according to the manufacturer’s protocol. 
The 16S rRNA genes were sequenced with an ABI 3730xl capillary DNA sequencer (PE 
Applied Biosystems), at Core Lab. KAUST, Saudi Arabia. 
Bacterial biomass 
Strains of halophilic bacteria were isolated into pure culture by streaking the samples onto 
three different solid media types, marine agar 2216 (Difco), plate count agar (Teknova), and 
R2A agar (Oxoid). These media were supplemented with either 10% or 20% NaCl to adjust 
salinity. All plates were incubated at 30°C and inspected daily for two weeks. Colonies with 
different morphologies were picked and pure cultures of these colonies were obtained after 
three transfers. Taxonomic identifications were based on 16S rRNA gene sequencing. DNA 
extraction of the pure cultures, 16S rRNA gene amplification, and sequencing were 
performed according to [18]. A BLASTN search was used to identify strains to their closest 
relatives in GenBank. To prepare extracts, bacteria were grown in 1 L of Marine Broth 
(Difco) supplemented with NaCl. Cultures were incubated at 30°C in a shaking incubator and 
harvested after two weeks by centrifugation. Cell pellets were frozen at −80°C until used for 
extract preparation. 
Extract preparation 
Lipophilic, i.e. chloroform and hydrophilic, i.e. 70% ethanol, extracts of 12 strains of marine 
bacteria were prepared at a concentration of 100 mg mL-1 (speedvac dried material/mL of 
solvent). Solutions were sonicated with ultra-sound probe (Biologics Inc., Model 150 V/T) 
for 3 x 2 minutes on ice. The solutions were centrifuged at 10000 g for 15 minutes; the 
supernatants were recovered and stored at −20°C. 
Cell culture 
MCF-7 (Breast Adenocarcinoma), DU145 (Prostate carcinoma) and HeLa (Cervical 
carcinoma) were obtained from the American Type Cell Culture Collection (ATCC, 
Manassas, VA). All cell lines were cultured in DMEM (Dulbecco’s Modified Eagle’s 
Medium), supplemented with 10% FCS (Fetal calf serum), penicillin (100U/ml) and 
streptomycin (100 µg/ml) at 5% CO2 in a 37°C incubator. 
MTT assay 
The cytotoxicity of marine bacterial extracts was estimated by MTT (3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. Cells were seeded at a 
density of 2.5 x 103 cells per well in a 384-well culture plates and treated with 1 mg/mL 
marine bacterial extract for 24 and 48 hr (hours). Cells were treated with 5 mM H2O2 as a 
positive control. Following incubation with extracts, 5 µl of sterile MTT (5 mg/mL) dissolved 
in PBS was added to each well and incubated with cells for 4 hr followed by the addition of 
30 µl of solubilisation solution (10% SDS, 10 mM HCl) which was incubated with cells for 
16 hr at 37°C. The OD (optical density) of each well was measured at 595 nm using a 
microtiter plate reader (BMG Labtech PHERAstar FS, Germany) and results were analyzed 
using Microsoft Office Excel©. 
APOPercentage assay 
The cells were seeded in 96 well plates at a density of 5 x 103 cells per well in duplicate in 90 
µl of media. After 24 hr, cells were treated with marine bacterial extracts diluted in complete 
DMEM to a final concentration of 1 mg/mL and incubated at 37°C for 48 hr. Cells were 
treated with 2.5 mM H2O2 for 30 minutes as a positive control. The cells were stained with 
APOPercentage dye as per manufacturer’s instructions (Biocolor, UK). Duplicates were 
pooled, the OD was measured at 550 nm absorbance using a microtiter plate reader (BMG 
Labtech PHERAstar FS, Germany) and percentage staining was calculated. 
Statistical analysis 
Student’s t-test was used to compare the samples (treated vs. Untreated) and were noted to be 
statistically significantly different where p<0.05. All statistics including mean and SD 
calculations were performed using Microsoft Office Excel©. 
Results 
Microbial isolates 
Twelve strains of marine bacteria were isolated from the Kebrit Deep, Nereus Deep, 
Discovery Deep and Erba Deep of the Red Sea (Table 1). The isolation of bacteria and their 
culturing were done by Red Sea Research Center at King Abdullah University of Science and 
Technology. Total 20 extracts i.e. lipophilic (chloroform) and hydrophilic (70% ethanol) have 
been investigated for their anticancer potential against above mentioned three human cancer 
cell lines. 
Table 1 Taxonomic identification, location of collection and source of origin for 12 
microbial strains 
Chloroform 
Extract 
Ethanol 
Extract Isolate Source Closest relative Similarity 
GenBank 
access no. 
Ref 
- 1E P1-17B Kebrit interface 
Sulfitobacter 
pontiacus 99% NR_026418.1 [19] 
2C - P1-37B Nereus interface 
Halomonas 
meridiana 100% AF212217.2 [20] 
3C 3E P3-82 Erba interface 
Halomonas 
meridiana 100% AF212217.2 [20] 
4C 4E P5-16A Kebrit interface 
Halomonas 
axialensis 100% NR_027219.1 [21] 
5C 5E P5-16B Kebrit interface 
Halomonas 
axialensis 100% NR_027219.1 [21] 
6C 6E P5-37A Nereus interface 
Halomonas 
meridiana 99% AF212217.2 [20] 
7C 7E P5-82 Erba interface 
Idiomarina 
baltica 99% AJ440215.1 [22] 
8C - P1-37A Nereus interface 
Marinobacter 
bryozoorum 98% NR_027192.1 [23] 
9C 9E P1-82 Erba interface 
Halomonas 
meridiana 100% NR_042066.1 [24] 
10C 10E P1-16B Kebrit interface 
Vibrio 
sinaloensis 98% NR_043858.1 [25] 
11C 11E P3-37A Nereus interface 
Halomonas 
aquamarina 100% HQ188659.1 [26] 
12C - P6-86 Discovery interface 
Chromohaloba-
cter salexigens 99% EU868854.1 [27] 
Cytotoxic activities of bacterial extracts 
Cytotoxic activities for the extracts were assessed by MTT assay. The growth inhibitions 
were measured after treating the cell lines with microbial extracts for 24 hr (Figures 1, 2 and 
3). Out of total 20 bacterial extracts, 13 extracts i.e. 2C, 5C, 7C, 8C, 11C, 1E, 4E, 5E, 6E, 
7E, 9E, 10E and 11E displayed maximum growth inhibitory effects on different cancer cell 
lines. The specific activity of different extracts for particular cell lines may be attributed to 
the presence of different polarity compounds. Extracts 2C, 5C, 11C, 4E, 5E, 7E and 11E 
(Figure 1) showed 40-60% of growth inhibition in MCF-7 cells. 
Figure 1 Percent growth inhibition of MCF-7 cells after treatment with 1 mg/mL 
marine bacterial extracts for 24 hr. Data were normalized to DMSO treatment controls, 
and error bars represent the standard deviation for triplicate experiments. Values marked as 
asterisk (*p<0.05 and **p<0.01) are significantly different from untreated control (Un). +ve 
represents positive control (H2O2). 
Figure 2 Percent growth inhibition of HeLa cells after treatment with 1 mg/mL marine 
bacterial extracts for 24 hr. Data were normalized to DMSO treatment controls, and error 
bars represent the standard deviation for triplicate experiments. Values marked as asterisk 
(*p<0.05 and **p<0.01) are significantly different from untreated control (Un). +ve 
represents positive control (H2O2). 
Figure 3 Percent growth inhibition of DU145 cells after treatment with 1 mg/mL marine 
bacterial extracts for 24 hr. Data were normalized to DMSO treatment controls, and error 
bars represent the standard deviation for triplicate experiments. Values marked as asterisk 
(*p<0.05 and **p<0.01) are significantly different from untreated control (Un). +ve 
represents positive control (H2O2). 
Bacterial extracts 5C, 1E, 5E and 7E (Figure 2) demonstrated 50-70% growth inhibition 
against HeLa cells. Extracts 1E and 5E were found to be highly active against HeLa with 
growth inhibition of 70% and 60% respectively. Similarly, extracts 1E, 5E, 7E and 9E 
inhibited the growth of DU145 cells by 40% or more after 24 hr of treatment (Figure 3). 
Extract 1E was the most active fraction against DU145 with about 70% growth inhibition. 
The comparison of data (Figures 1, 2 and 3) revealed that extract 11E is most active in MCF-
7 but comparatively has low cytotoxic activity in HeLa and DU145 cells. Also, extracts 4E 
and 6E are only active against HeLa cells (20% and 30% growth inhibition respectively) and 
do not affect MCF-7 and DU145 cells. Overall, the results showed that marine bacterial 
extracts have cell line specific cytotoxic activity. 
To observe the long term effects of the bacterial extracts on the growth of cancer cell lines, 
the lead extracts (2C, 5C, 7C, 8C, 11C, 1E, 4E, 5E, 6E, 7E, 10E and 11E) were further 
evaluated for cytotoxicity at 48 hr time point. These extracts were selected based on their 
activities and availability. Cell growth inhibition induced by some of the extracts was 
increased with time (Table 2) while for others the growth inhibition decreases slightly which 
may indicate the recovery of the cells, especially in the case of MCF-7 cells. 
Table 2 The comparison of percentage growth inhibition of HeLa, MCF-7 and DU145 
cells after treatment with 1 mg/mL marine bacterial extracts in triplicate for 24 and 48 
hr 
Marine 
Bacterial 
Extract 
HeLa MCF-7 DU145 
24 hr 48 hr 24 hr 48 hr 24 hr 48 hr 
2C 44.906 58.003 61.307 78.608 30.233 86.682 
5C 50.000 41.931 47.173 7.654 33.194 50.260 
7C 41.094 38.250 21.555 −17.160 16.597 15.263 
8C 10.151 23.494 −3.180 −25.303 −9.779 16.262 
11C 39.736 50.176 57.244 36.271 −8.074 54.699 
1E 69.434 61.787 44.700 13.560 66.836 59.324 
4E 20.604 34.164 −3.710 −10.350 2.661 37.471 
5E 59.472 41.556 40.901 24.234 51.077 47.287 
6E 27.547 15.256 1.502 −23.946 −7.775 21.345 
7E 51.434 42.027 40.283 20.021 46.202 47.725 
10E 21.925 9.215 20.936 8.992 10.616 15.956 
11E 22.453 29.769 59.806 16.475 15.371 45.672 
Data were normalized to DMSO treatment control. 
Apoptotic evaluations 
To further confirm that the mode of cell death is via apoptosis, the lead marine bacterial 
extracts (2C, 5C, 11C, 1E, 4E, 5E, 7E, 10E and 11E) were evaluated by APOPercentage 
assay. The results for this assay showed that most of the lead extracts induced apoptosis in 
HeLa cells (Figure 4), while in DU145 and MCF-7 cells, no significant apoptotic effect was 
observed at 48 hr time point, however, the bacterial extract 2C showed high apoptotic activity 
in MCF-7 cells (Figure 4). 
Figure 4 Percent apoptosis in HeLa, DU145 and MCF-7 cells after treatment with 1 
mg/mL marine bacterial extracts for 24 hr. The treatment of extracts was done for 48 hr in 
duplicates. Data were normalized to untreated controls. 
Discussion 
The results showed that most of the microbial extracts from the brine pools of the Red Sea 
have displayed significant cytotoxic and apoptotic activity. Cytotoxicity which was measured 
by MTT assay (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide), targets the 
activity of succinate dehydrogenase in mitochondria which in turn reduces the tetrazolium 
salt into formazan crystals [28]. The intensity of the color of formazan dye correlates to the 
number of viable cells. The isolates P1-37B (2C) and P3-37A (11C and 11E) which has 
100% sequence similarity to Halomonas (Table 1) showed about 60% growth inhibition 
(Figure 1) in MCF-7 cell line. Not much work has been done on the anticancer activities of 
Halomonas sp. and very few studies have been reported so far. Marine bacterial strain GWS-
BW-H8hM was reported to inhibit growth of HM02 (gastric adenocarcinoma), HepG2 
(hepatocellular carcinoma) and MCF7 cell lines and induce apoptosis via cell cycle arrest 
[29]. Highly heterogeneous polymers i.e. exopolysaccharides (EPSs) and sulphated EPSs 
isolated from H. stenophila sp. inhabiting hypersaline environment have also been reported 
for their pro-apoptotic effects on T-leukemia cells [30]. A range of amphiphilic siderophores, 
loihichelins A-F, consisting of an octapeptide comprised of D-threo-β-hydroxyaspartic acid, 
D-serine, L-glutamine, L-serine, L-N(δ)-acetyl-N(δ)-hydroxyornithine, dehydroamino-2-
butyric acid, D-serine, and cyclic N(δ)-hydroxy-D-ornithine, appended by one of a series of 
fatty acids ranging from decanoic acid to tetradecanoic acid have been isolated from cultures 
of the marine bacterium Halomonas sp. LOB-5 [8]. The isolation of cytotoxic 
hydroxyphenylpyrrole-dicarboxylic acids i.e. 3-(4_-hydroxyphenyl)-4-phenylpyrrole-2,5-
dicarboxylic acid (HPPD-1), 3,4-di-(4_-hydroxy-phenyl)pyrrole-2,5- dicarboxylic acid 
(HPPD-2) and the literature-known indole derivatives 3-(hydroxyacetyl)-indole, indole-3- 
carboxylic acid, indole-3-carboxaldehyde, and indole-3-acetic acid have also been reported 
from a marine Halomonas sp. [31]. Both HPPD-1 and HPPD-2 have shown potent antitumor- 
promoting activities. Two most active extracts were obtained from the isolates P1-17B (1E) 
and P5-16B (5E), which inhibited the cell growth by 50-70% (Figures 2 and 3) in HeLa and 
DU145 cells and showed sequence similarity of 100% to Sulfitobacter and Halomonas 
respectively (Table 1). The cytotoxic activity observed in isolates P1-37B and P3-37A 
(Halomonas) could be due to the above mentioned cytotoxic compounds from Halomonas 
sp.. No published records were found in PubMed regarding the cytotoxic activities and 
isolation of bioactive molecules from Sulfitobacter. The most prominent effect was found for 
extract 1E (Isolate P1-17B- Sulfitobacter) for HeLa and DU145 cell lines which makes it a 
suitable candidate for future isolation of bioactive molecules. Cytotoxic effects for the most 
active extracts were also observed at 48 hr time point and activity for some of these extracts 
were found to be lower than that at 24 hr (Table 2, see non-bold numbers). It may be due to 
the recovery of the cells from the effects of these extracts. In general the hydrophilic extracts 
were found to be more active than lipophilic extracts, which may indicate the presence of 
significant amount of cytotoxic compounds in the polar fractions as compared to the non-
polar fractions. 
To further confirm the cell death via apoptotic mode, APOPercentage assay was performed 
on the most active extracts. Apoptosis is a form of a programmed cell death where cell 
undergo specific hallmark changes during progression towards death [32]. It has been 
established that apoptosis plays a key role in death of cancer as well as normal cells [33]. The 
APOPercentage assay (http://www.biocolor.co.uk/) captures apoptotic cells representing a 
hallmark change on the surface of plasma membranes i.e. phosphatidylserine (PS) 
externalization. PS is found in the inner leaflet and is exposed to outer leaflet during 
apoptosis and this externalized PS acts as a recognition tag for multiple processes including 
macrophages and phagocytosis [34,35]. The maximum apoptotic activity was displayed by 
isolate P1-37B (2C) in both HeLa as well as MCF-7 cells (Figure 4). Similar studies targeting 
bacterial extracts from other marine habitats have been published previously, mainly 
targeting cyanobacteria [36] and bacteria associated with other marine organisms such as 
seaweeds and invertebrates [37] and sponges [38,39]. 
The cell line specific activity of the extracts may be attributed to the different polarity 
compounds. Previous studies on different cancer cell lines have shown that the variable 
response of cell lines towards apoptosis inducers may also be attributed to the cancer type i.e. 
biological differences in cell lines and different mechanisms of action of programmed cell 
death prevalent in different cancer cell lines [40]. Even the timeline of progression through 
apoptosis process can vary among cell lines [41,42]. 
Conclusions 
In conclusion, present work showed that extracts of most of the marine bacterial strains 
collected from interface of brine pools and sea water of the Red Sea have displayed 
significant growth inhibitory and apoptotic effect on the various cancer cell lines. The 
extracts from the isolates P1-37B and P3-37A (Halomonas) and P1-17B (Sulfitobacter) have 
been found to be the most potent against tested cancer cell lines and could be the lead 
candidates for the future work of isolation and structure elucidation of bioactive molecules. 
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